Skip to search formSkip to main content

MF 934

Known as: MF-934 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The antimicrobial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated by a standardized agar dilution method… Expand
Is this relevant?
1993
1993
The antibacterial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated against 1095 clinical isolates and… Expand
  • table 1
  • table I
  • table I
Is this relevant?
1992
1992
Ocular pharmacokinetics of rufloxacin (MF 934), a new monofluorinated quinolone derivative, has been investigated in rabbits. A… Expand
Is this relevant?
1989
1989
Rufloxacin (MF-934) is a new quinolone which shows in vitro antibacterial activity against E. coli, Salmonella, Klebsiella… Expand
Is this relevant?
1989
1989
  • A. Farina
  • Journal of pharmaceutical and biomedical analysis
  • 1989
A simple and rapid fluorimetric method for the determination of 9-fluoro-10-[N-(4'-methyl)piperazinyl]-7-oxo-2,3-dihydro-7H… Expand
Is this relevant?
1988
1988
The kinetics of a new fluoroquinolone, rufloxacin (MF-934), have been studied in rats, dogs and monkeys. The drug is… Expand
Is this relevant?
1987
1987
A series of pyridobenzothiazine acid derivatives was synthesized and their in vitro antibacterial activity was evaluated. The 1,4… Expand
Is this relevant?